2
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Neoplasms
2
Sepsis
1
Neutropenia
1
Hematological Infection
1
Gram-Negative Bacterial Infections
1
Colorectal Neoplasms
1
Anastomotic Leak
1
Interventions
pegfilgrastim
30
Filgrastim
29
Cyclophosphamide
10
pegylated granulocyte colony-stimulating factor
8
Docetaxel
8
Etoposide
7
Cytarabine
7
Ciprofloxacin
6
Cefepime
6
Vancomycin
5
Leucovorin
5
Fluorouracil
5
eflapegrastim
4
Granulocyte Colony-Stimulating Factor
4
Doxorubicin
4
Peripheral Blood Stem Cell Transplantation
3
Mitoxantrone
3
Methotrexate
3
Levofloxacin
3
Irinotecan
3
Idarubicin
3
Daunorubicin
3
Cyclosporine
3
Caspofungin
3
Carboplatin
3
Amikacin
3
trifluridine tipiracil drug combination
2
plerixafor
2
liposomal amphotericin B
2
Vincristine
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neutropenia
×
Colistin
×
Clear all
NCT01931592
2017-05-08
CLEAR
University of Cologne
Phase 2/3
Terminated
29 enrolled